Skip Navigation

Cardiovascular Research 2004 64(3):516-525; doi:10.1016/j.cardiores.2004.08.009
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sheikh, F.
Right arrow Articles by Cattini, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheikh, F.
Right arrow Articles by Cattini, P. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Inhibition of TGFβ signaling potentiates the FGF-2-induced stimulation of cardiomyocyte DNA synthesis

Farah Sheikha,1, Cheryl J.A. Hirsta,b, Yan Jina, Margaret E. Bocka, Robert R. Fandrichb, Barbara E. Nickelb, Brad W. Doblea,b, Elissavet Kardamia,b,c and Peter A. Cattinia,*

aDepartment of Physiology, University of Manitoba, 730 William Avenue, Winnipeg, Manitoba, Canada R3E 3J7
bInstitute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, 351 Tache Avenue, Winnipeg, Manitoba, Canada R2H 2A6
cDepartment of Human Anatomy and Cell Science, University of Manitoba, 730 William Avenue, Winnipeg, Manitoba, Canada R3E 3J7

* Corresponding author. Tel.: +1 204 789 3696; fax: +1 204 789 3934. Email address: peter_cattini{at}umanitoba.ca

Objective:: Added transforming growth factor beta (TGFβ) inhibits the proliferation of immature cardiomyocytes. We have now examined the hypothesis that suppression of endogenous TGFβ signaling will boost the proliferative response (DNA synthesis) of cardiac myocytes to serum and/or to the mitogenic factor fibroblast growth factor-2 (FGF-2).

Methods and results:: Overexpression of a kinase-deficient TGFβ type II receptor (TGFβRII{Delta}KD) resulted in a 2.8-fold increase in cardiomyocyte DNA synthesis in serum-rich cultures, an effect requiring active FGFR-1 since it was not observed in the presence of excess kinase-deficient FGFR-1. This finding suggested that endogenous TGFβ–TGFβRII suppressed endogenous FGFR-1-mediated signals that stimulate or are permissive for DNA synthesis. TGFβ had no effect, however, on the FGF-2-induced acute stimulation of extracellular signal regulated kinase1/2. FGF-2, added in the absence or presence of TGFβ inhibition, elicited a 3- or a 13-fold stimulation of DNA synthesis, respectively, pointing to a synergistic effect.

Conclusion:: Inhibition of TGFβRII-transduced signaling upregulates the proliferative response of cardiomyocytes to serum, and greatly potentiates the stimulatory effect of FGF-2. A combinatorial strategy including activation of FGF-2 and inhibition of TGFβ-triggered signal transduction may be required for maximal stimulation of immature cardiomyocyte DNA synthesis.

KEYWORDS Cardiomyocytes; DNA synthesis; Receptor crosstalk; Fibroblast growth factor-2; Transforming growth factor β; Dominant negative receptors


1 Current address: Institute of Molecular Medicine, School of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.

Time for primary review 22 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.